Axa’s Elanco Animal Health ELAN Stock Holding History

Axa’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60,994	Closed	-$880K	–	1107
2024 Q2	$880K	Sell	60,994 -32,839	-35%	-$525K	﹤0.01%	891
2024 Q1	$1.53M	Hold	93,833	–	–	﹤0.01%	792
2023 Q4	$1.4M	Buy	+93,833	New	+$1.06M	﹤0.01%	790
2019 Q2	–	Sell	-121,339	Closed	-$3.89M	–	1303
2019 Q1	$3.89M	Buy	+121,339	New	+$3.73M	0.02%	707

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Axa's ELAN Position: Q3 2024 in Review

Axa sold out of Elanco Animal Health (ELAN) in Q3 2024, closing a stake of 60,994 shares — an estimated $880K sold.

Axa first reported a position in ELAN in Q1 2019 and held it in 4 quarters. The position peaked at $3.89M in Q1 2019. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

Axa reported no remaining Elanco Animal Health position as of Q3 2024 after selling out during the quarter.
Axa sold 60,994 Elanco Animal Health shares in Q3 2024, an estimated $880K.
Axa first reported a position in Elanco Animal Health in Q1 2019 and held it in 4 quarters.
Axa's Elanco Animal Health position peaked at $3.89M in Q1 2019.
388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on Axa's 13F filing for Q3 2024, filed 14 Nov 2024.